Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma (Q33415219)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma |
scientific article |
Statements
1 reference
Phase II study evaluating the efficacy, safety, and pharmacodynamic correlative study of dual antiangiogenic inhibition using bevacizumab in combination with sorafenib in patients with advanced malignant melanoma (English)
1 reference
Devalingam Mahalingam
1 reference
Laeeq Malik
1 reference
Muralidhar Beeram
1 reference
Jordi Rodon
1 reference
Kamalesh Sankhala
1 reference
Alain Mita
1 reference
Daniel Benjamin
1 reference
Norma Ketchum
1 reference
Joel Michalek
1 reference
Anthony Tolcher
1 reference
John Wright
1 reference
John Sarantopoulos
1 reference
10 May 2014
1 reference
1 reference
74
1 reference
77-84
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference